Ken Fisher’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.3M | Sell |
450,603
-8,687,613
| -95% | -$695M | 0.01% | 290 |
|
|
2025
Q4 | $871M | Buy |
9,138,216
+677,191
| +8% | +$66.4M | 0.3% | 84 |
|
|
2025
Q3 | $826M | Buy |
8,461,025
+755,641
| +10% | +$78.3M | 0.3% | 89 |
|
|
2025
Q2 | $828M | Buy |
7,705,384
+939,834
| +14% | +$95.1M | 0.33% | 84 |
|
|
2025
Q1 | $683M | Buy |
6,765,550
+964,638
| +17% | +$97.1M | 0.3% | 87 |
|
|
2024
Q4 | $518M | Buy |
5,800,912
+1,028,977
| +22% | +$90.6M | 0.21% | 90 |
|
|
2024
Q3 | $400M | Buy |
4,771,935
+694,585
| +17% | +$54.8M | 0.16% | 101 |
|
|
2024
Q2 | $314M | Buy |
4,077,350
+66,996
| +2% | +$4.9M | 0.14% | 106 |
|
|
2024
Q1 | $275M | Buy |
4,010,354
+24,555
| +0.6% | +$1.58M | 0.13% | 115 |
|
|
2023
Q4 | $230M | Buy |
3,985,799
+15,357
| +0.4% | +$820K | 0.12% | 123 |
|
|
2023
Q3 | $210M | Buy |
3,970,442
+131,207
| +3% | +$6.88M | 0.12% | 137 |
|
|
2023
Q2 | $208M | Buy |
3,839,235
+51,352
| +1% | +$2.68M | 0.11% | 147 |
|
|
2023
Q1 | $190M | Buy |
3,787,883
+36,948
| +1% | +$1.74M | 0.12% | 151 |
|
|
2022
Q4 | $174M | Buy |
3,750,935
+50,033
| +1% | +$2.17M | 0.12% | 145 |
|
|
2022
Q3 | $143M | Buy |
3,700,902
+95,591
| +3% | +$3.83M | 0.11% | 148 |
|
|
2022
Q2 | $134M | Buy |
3,605,311
+100,331
| +3% | +$4.08M | 0.1% | 137 |
|
|
2022
Q1 | $155M | Buy |
3,504,980
+130,838
| +4% | +$5.67M | 0.09% | 135 |
|
|
2021
Q4 | $143M | Buy |
3,374,142
+94,661
| +3% | +$3.98M | 0.08% | 152 |
|
|
2021
Q3 | $142M | Buy |
3,279,481
+131,038
| +4% | +$5.8M | 0.09% | 137 |
|
|
2021
Q2 | $135M | Buy |
3,148,443
+118,503
| +4% | +$4.99M | 0.08% | 138 |
|
|
2021
Q1 | $117M | Buy |
3,029,940
+114,430
| +4% | +$4.33M | 0.08% | 147 |
|
|
2020
Q4 | $105M | Buy |
2,915,510
+119,530
| +4% | +$4.31M | 0.08% | 155 |
|
|
2020
Q3 | $107M | Buy |
2,795,980
+84,556
| +3% | +$3.26M | 0.09% | 140 |
|
|
2020
Q2 | $95.2M | Buy |
2,711,424
+589,237
| +28% | +$21.2M | 0.09% | 140 |
|
|
2020
Q1 | $69.2M | Buy |
2,122,187
+2,104,416
| +11,842% | +$82.2M | 0.09% | 145 |
|
|
2019
Q4 | $804K | Buy |
17,771
+438
| +3% | +$18.3K | ﹤0.01% | 611 |
|
|
2019
Q3 | $705K | Buy |
17,333
+2,289
| +15% | +$97K | ﹤0.01% | 644 |
|
|
2019
Q2 | $647K | Buy |
15,044
+4,957
| +49% | +$191K | ﹤0.01% | 640 |
|
|
2019
Q1 | $387K | Sell |
10,087
-276
| -3% | -$10.5K | ﹤0.01% | 671 |
|
|
2018
Q4 | $366K | Buy |
+10,363
| New | +$376K | ﹤0.01% | 690 |
|
Other funds holding BSX
VCM
VPM
Ken Fisher's BSX Position: Q1 2026 in Review
Ken Fisher reduced its Boston Scientific (BSX) stake by 95% in Q1 2026, selling an estimated $695M and leaving 450,603 shares worth $28.3M. The position accounts for 0.01% of the portfolio, ranked #290.
Ken Fisher first reported a position in BSX in Q4 2018 and has held it in 30 quarters since. The position peaked at $871M in Q4 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Ken Fisher held 450,603 shares of Boston Scientific worth $28.3M as of Q1 2026.
- Ken Fisher sold 8,687,613 Boston Scientific shares in Q1 2026, an estimated $695M.
- Boston Scientific made up 0.01% of Ken Fisher's portfolio in Q1 2026, its #290 holding.
- Ken Fisher first reported a position in Boston Scientific in Q4 2018 and has held it in 30 quarters since.
- Ken Fisher's Boston Scientific position peaked at $871M in Q4 2025.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.